Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [ChIP-seq]

ABSTRACT: SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [ChIP-seq]

PROVIDER: PRJNA892530 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR21983420_1.fastq.gz	Fastqsanger.gz
	SRR21983420_2.fastq.gz	Fastqsanger.gz
	SRR21983421_1.fastq.gz	Fastqsanger.gz
	SRR21983421_2.fastq.gz	Fastqsanger.gz
	SRR21983422_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 10

Similar Datasets

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer

Project description:SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer

| PRJNA892525 | ENA

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [RNA-seq]

Project description:We investigate the impact of SIRT6-overexpression (SIRT6-OE) in the breast cancer mouse model Delta16HER2. After an initial delay in the tumor onset, starting form 20 weeks of age, SIRT6-OE induces a more aggressive phenotype of Delta16HER2 tumors, promoting the formation of more tumors and metastases with respect to controls. SIRT6 can regulate gene expression and chromatin integrity via deacetylation of H3K9ac. Therefore, to gain mechanistic insights, we performed H3K9ac ChIP-seq and RNA-seq on tumors from Delta16HER2/SIRT6-OE and Delta16HER2 mice, harvested at 20 weeks of age.

2023-12-31 | GSE216185 | GEO

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [ChIP-seq]

2023-12-31 | GSE216183 | GEO

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [RNA-seq]

Project description:SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer [RNA-seq]

| PRJNA892528 | ENA

SIRT6 overexpression predicts high risk of metastasis and relapse in Delta16HER2-positive breast cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-12-31 | GSE216186 | GEO

SIRT6 promotes metastasis and relapse in HER2-positive breast cancer.

Project description: Not available

| S-EPMC10713583 | biostudies-literature

SIRT6 Overexpression Counteracts Chromatin Aging

Project description:Aging is associated with detrimental changes in chromatin structure and gene expression, contributing to inflammation, metabolic decline and tissue dysfunction. SIRT6, a histone deacetylase, plays a key role in maintaining chromatin integrity and promoting longevity. Here, we show that aging leads to increased chromatin accessibility in the murine liver, accompanied by upregulation of inflammation and downregulation of metabolic pathways. Remarkably, SIRT6 overexpression reversed these changes, reducing inflammation and enhancing metabolic function. Notably, ETS family members were enriched in regions with increased accessibility during aging, while liver-enriched transcription factors (LETFs) were enriched in regions with reduced accessibility. ChIP-seq analyses of H3K9ac and H3K56ac binding showed that H3K9ac, but not H3K56ac, is associated with increased accessibility during aging, and that SIRT6 can reverse this effect. Furthermore, AAV-mediated SIRT6 overexpression in aged mice demonstrated that SIRT6 not only slows age-related chromatin changes but can also reverse them, rejuvenating chromatin accessibility to a youthful state.

2026-04-13 | GSE296168 | GEO

SIRT6 Overexpression Counteracts Chromatin Aging [ATAC-Seq_tg]

2026-04-12 | GSE294103 | GEO

SIRT6 Overexpression Counteracts Chromatin Aging [ChIP-Seq]

2026-04-12 | GSE294085 | GEO

SIRT6 Overexpression Counteracts Chromatin Aging [RNA-Seq]

2026-04-12 | GSE294067 | GEO